XML 24 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Impact of Error on Financial Statements
The impact of the error on the consolidated balance sheet as of December 31, 2018 is presented below.
 
 
As of December 31, 2018
 
 
Previously Reported
 
Adjustment
 
Revised
Balance Sheet:
 
 
 
 
 
 
Long-term deferred revenue
 
2,506,898

 
(787,895
)
 
1,719,003

Total liabilities
 
17,769,761

 
(787,895
)
 
16,981,866

Accumulated deficit
 
(122,907,794
)
 
787,895

 
(122,119,899
)

The impact of the error on the consolidated statements of stockholders' deficit is presented below.

 
 
As Previously Reported
 
Adjustment
 
Revised
Statement of Stockholders' Deficit:
 
 
 
 
 
 
Cumulative effect of adoption of ASC 606 for the year ended December 31, 2018
 
8,929,204

 
787,895

 
9,717,099

Accumulated deficit at December 31, 2018
 
(122,907,794
)
 
787,895

 
(122,119,899
)
  Total stockholders' deficit at December 31, 2018
 
(11,553,796
)
 
787,895

 
(10,765,901
)
Deferred Revenue, by Arrangement, Disclosure
Changes in deferred revenue were as follows:
Twelve Months Ended December 31, 2019
 
Balance at December 31, 2018
9,366,490

   Deferral of revenue
14,626,933

   Recognition of revenue
(16,543,571
)
   Change in reserves
(94,582
)
Balance at December 31, 2019
$
7,355,270

Right of Use Assets and Liabilities and Lease Costs
We have various operating leases for office facilities that expire through 2021. Below is a summary of our right of use assets and liabilities as of December 31, 2019.

Right of use assets
$
1,842,254

Lease liability obligations, current
1,655,522

Lease liability obligations, less current portion
624,859

Total lease liability obligations
$
2,280,381

Weighted-average remaining lease term
1.36

Weighted-average discount rate
5.99
%

    

Our operating lease costs for the year ended December 31, 2019 were as follows:

 
Year Ended December 31, 2019
Components of lease expense:
 
Operating lease cost
2,495,865

Sublease income
(623,776
)
Net lease cost
$
1,872,089


Future Minimum Lease Payments
Approximate future minimum lease payments for our right of use assets over the remaining lease periods as of December 31, are as follows:
2020
1,754,189

2021
639,526

Total minimum lease payments
2,393,715

Less interest
(113,334
)
Present value of lease liabilities
2,280,381


Schedule of Intangible Assets and Goodwill
The gross carrying amount and accumulated amortization of goodwill and other intangible assets as of December 31, 2019 and 2018 are as follows: 
 
 
December 31, 2019
 
December 31, 2018
Goodwill
 
$
4,150,339

 
$
4,150,339

Other intangible assets:
 
 

 
 

Gross carrying amount
 
$
3,947,103

 
$
3,891,241

Accumulated amortization
 
(3,889,385
)
 
(3,799,907
)
Net carrying amount
 
$
57,718

 
$
91,334


Summary of Software Development Costs
The gross carrying amount and accumulated amortization of software development costs as of December 31, 2019 and 2018 are as follows:
 
 
December 31, 2019
 
December 31, 2018
Software development costs:
 
 
 
 
Gross carrying amount
 
$
2,950,132

 
$
2,950,132

Accumulated amortization
 
(2,923,120
)
 
(2,861,363
)
Software development costs, net
 
$
27,012

 
$
88,769


Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following represents the common stock equivalents that were excluded from the computation of diluted shares outstanding because their effect would have been anti-dilutive for the years ended December 31, 2019 and 2018:
 
 
Year Ended December 31,
 
 
2019
 
2018
Stock options, warrants and restricted stock
 
1,263,009

 
29,973

Series A redeemable convertible preferred stock
 
87,815

 
87,815

Total anti-dilutive common stock equivalents
 
1,350,824

 
117,788


Computation of Earnings Per Share

The following represents the common stock equivalents that were excluded from the computation of diluted shares outstanding because their effect would have been anti-dilutive for the years ended December 31, 2019 and 2018:
 
 
Year Ended December 31,
 
 
2019
 
2018
Stock options, warrants and restricted stock
 
1,263,009

 
29,973

Series A redeemable convertible preferred stock
 
87,815

 
87,815

Total anti-dilutive common stock equivalents
 
1,350,824

 
117,788


 
The following represents a reconciliation of the numerators and denominators of the basic and diluted EPS computation:
 
 
Year Ended December 31,
 
 
2019
 
2018
Numerator:




Net loss

$
(1,751,954
)
 
$
(906,714
)
Effects of Series A redeemable convertible preferred stock:

 
 
 
Less: Accrual of Series A redeemable convertible preferred stock dividends

1,157,762

 
1,035,977

Less: Accretion to redemption value of Series A redeemable convertible preferred stock

389,811

 
254,212

Less: Deemed dividend on Series A redeemable convertible preferred stock
 
$

 
$
2,269,042

Net loss attributable to common stockholders

$
(3,299,527
)
 
$
(4,465,945
)
 

 
 
 
Denominator:

 
 
 
Weighted average basic shares outstanding

5,900,621

 
933,301

Weighted average diluted shares outstanding

5,900,621

 
933,301

 

 
 
 
EPS:

 
 
 
Basic net loss per share attributable to common stockholders

$
(0.56
)
 
$
(4.79
)
Diluted net loss per share attributable to common stockholders

$
(0.56
)
 
$
(4.79
)